Malignancy risk of hyperfunctioning thyroid nodules compared with non-toxic nodules: systematic review and a meta-analysis

被引:21
作者
Lau, Lorraine W. [1 ,2 ]
Ghaznavi, Sana [1 ,2 ]
Frolkis, Alexandra D. [1 ]
Stephenson, Alexandra [3 ]
Robertson, Helen Lee [4 ]
Rabi, Doreen M. [2 ,5 ]
Paschke, Ralf [1 ,2 ,6 ,7 ,8 ,9 ]
机构
[1] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada
[2] Univ Calgary, Cumming Sch Med, Sect Endocrinol & Metab, Dept Med, Calgary, AB, Canada
[3] Univ Calgary, Arnie Charbonneau Canc Inst, Cumming Sch Med, Calgary, AB, Canada
[4] Univ Calgary, Clin Med Hlth Sci Lib, Calgary, AB, Canada
[5] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada
[6] Univ Calgary, Cumming Sch Med, Dept Oncol, Calgary, AB, Canada
[7] Univ Calgary, Cumming Sch Med, Dept Pathol, Calgary, AB, Canada
[8] Univ Calgary, Cumming Sch Med, Dept Lab Med, Calgary, AB, Canada
[9] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada
关键词
Thyroid nodules; Malignancy; Hot nodule; Thyrotoxicosis; Thyroid cancer; THYROTROPIN RECEPTOR MUTATION; TOXIC MULTINODULAR GOITER; FINE-NEEDLE-ASPIRATION; HURTHLE CELL-CARCINOMA; FOLLICULAR CARCINOMA; ACTIVATING MUTATION; MANAGEMENT GUIDELINES; PHYSICAL-EXAMINATION; CONSECUTIVE PATIENTS; HOT NODULE;
D O I
10.1186/s13044-021-00094-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hyperfunctioning or hot nodules are thought to be rarely malignant. As such, current guidelines recommend that hot nodules be excluded from further malignancy risk stratification. The objective of this systematic review and meta-analysis is to compare the malignancy risk in hot nodules and non-toxic nodules in observational studies. Methods: Ovid MEDLINE Daily and Ovid MEDLINE, EMBASE, Scopus, and Web of Science databases were searched. Observational studies which met all of the following were included: (1) use thyroid scintigraphy for nodule assessment, (2) inclusion of both hyperfunctioning and non-functioning nodules based on scintigraphy, (3) available postoperative histopathologic nodule results, (4) published up to November 12, 2020 in either English or French. The following data was extracted: malignancy outcomes include malignancy rate, mapping of the carcinoma within the hot nodule, inclusion of microcarcinomas, and presence of gene mutations. Results: Among the seven included studies, overall incidence of malignancy in all hot thyroid nodules ranged from 5 to 100% in comparison with non-toxic nodules, 3.8-46%. Odds of malignancy were also compared between hot and non-toxic thyroid nodules, separated into solitary nodules, multiple nodules and combination of the two. Pooled odds ratio (OR) of solitary thyroid nodules revealed a single hot nodule OR of 0.38 (95% confidence interval (CI) 0.25, 0.59), toxic multinodular goiter OR of 0.51 (95% CI 0.34, 0.75), and a combined hot nodule OR of 0.45 (95% CI 0.31, 0.65). The odds of malignancy are reduced by 55% in hot nodules; however, the incidence was not zero. Conclusions: Odds of malignancy of hot nodules is reduced compared with non-toxic nodules; however, the incidence of malignancy reported in hot nodules was higher than expected. These findings highlight the need for further studies into the malignancy risk of hot nodules.
引用
收藏
页数:16
相关论文
共 98 条
  • [1] AUTONOMOUSLY FUNCTIONING THYROID-NODULES IN A PATIENT WITH A THYROTROPIN-SECRETING PITUITARY-ADENOMA - POSSIBLE CAUSE-EFFECT RELATIONSHIP
    ABS, R
    STEVENAERT, A
    BECKERS, A
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 131 (04) : 355 - 358
  • [2] Adam B, 2017, NUCL MED REV, V20, P117
  • [3] HYPERTHYROIDISM AND THYROID-CARCINOMA
    AHUJA, S
    ERNST, H
    [J]. ACTA ENDOCRINOLOGICA, 1991, 124 (02): : 146 - 151
  • [4] Survival analysis of 19 patients with toxic thyroid carcinoma
    Als, C
    Gedeon, P
    Rösler, H
    Minder, C
    Netzer, P
    Laissue, JA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09) : 4122 - 4127
  • [5] Systematic reviews in health care - Systematic reviews of evaluations of prognostic variables
    Altman, DG
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7306): : 224 - 228
  • [6] Angusti T, 2000, J NUCL MED, V41, P1006
  • [7] [Anonymous], NEWCASTLE OTTAWA SCA
  • [8] Hyperfunctioning differentiated thyroid carcinoma
    Appetecchia, M
    Ducci, M
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1998, 21 (03) : 189 - 192
  • [9] Papillary thyroid carcinoma mimicking an autonomous functioning nodule
    Ardito, G
    Vincenzoni, C
    Cirielli, C
    Guidi, ML
    Corsello, MS
    Modugno, P
    Fadda, G
    Saletnich, I
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1997, 23 (06): : 569 - 569
  • [10] MANAGEMENT OF THYROID-NODULES .2. SCANNING TECHNIQUES, THYROID SUPPRESSIVE THERAPY, AND FINE NEEDLE ASPIRATION
    ASHCRAFT, MW
    VANHERLE, AJ
    [J]. HEAD & NECK SURGERY, 1981, 3 (04): : 297 - 322